OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholangiocarcinoma in the Era of Immunotherapy
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 8
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 8
Showing 8 citing articles:
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Alexander Olkus, Aurelie Tomczak, Anne Berger, et al.
Targeted Oncology (2024) Vol. 19, Iss. 2, pp. 213-221
Open Access | Times Cited: 9
Alexander Olkus, Aurelie Tomczak, Anne Berger, et al.
Targeted Oncology (2024) Vol. 19, Iss. 2, pp. 213-221
Open Access | Times Cited: 9
Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells
Chutipa Chiawpanit, Methi Wathikthinnakorn, Nunghathai Sawasdee, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112273-112273
Open Access | Times Cited: 6
Chutipa Chiawpanit, Methi Wathikthinnakorn, Nunghathai Sawasdee, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112273-112273
Open Access | Times Cited: 6
Ad6-Based GM-CSF Expressing Vector Displays Oncolytic and Immunostimulatory Effects in an Immunocompetent Syrian Hamster Model of Cholangiocarcinoma
Daria S. Zabelina, I.D. Osipov, Д. Е. Маслов, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 162-162
Open Access
Daria S. Zabelina, I.D. Osipov, Д. Е. Маслов, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 162-162
Open Access
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
Stavros P. Papadakos, Ioanna Ε. Stergiou, Nikolina Gkolemi, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3434-3434
Open Access | Times Cited: 9
Stavros P. Papadakos, Ioanna Ε. Stergiou, Nikolina Gkolemi, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3434-3434
Open Access | Times Cited: 9
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies
Sharmila Fagoonee, Ralf Weiskirchen
Cells (2024) Vol. 13, Iss. 23, pp. 1935-1935
Open Access | Times Cited: 1
Sharmila Fagoonee, Ralf Weiskirchen
Cells (2024) Vol. 13, Iss. 23, pp. 1935-1935
Open Access | Times Cited: 1
Clinical characteristics and prognosis of early-onset cholangiocarcinoma: a population-based study
Fuli Gao, Xiaodan Xu, Ying Sun
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 183-191
Closed Access | Times Cited: 2
Fuli Gao, Xiaodan Xu, Ying Sun
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 183-191
Closed Access | Times Cited: 2
The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma
Peng Shen, Yinsheng Shi, Pengcheng Xu, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102430-102430
Closed Access
Peng Shen, Yinsheng Shi, Pengcheng Xu, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102430-102430
Closed Access
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
Federica Lo Prinzi, Francesca Salani, Margherita Rimini, et al.
The Oncologist (2024)
Open Access
Federica Lo Prinzi, Francesca Salani, Margherita Rimini, et al.
The Oncologist (2024)
Open Access
